no thumb

Centre to push pharma exports to China HYDERABAD: The Centre is committed to promoting pharmaceuticals exports to China, and other untapped markets, Union Commerce & Industry Ministry Suresh Prabhu said on Wednesday.

Inaugurating the 3-day International Exhibition of Pharmaceuticals & Healthcare, or ‘iPhex’, in New Delhi, Prabhu said with China agreeing to a high-level bilateral Round Table meeting it would clear the way for Indian companies to get greater market access and penetration in China.

“Our ministry is committed to promoting the pharmaceuticals industry globally,” Prabhu said at the exhibition organized by the Pharmaceuticals Export Promotion Council of India (Pharmexcil). He said that with a view to enabling the Indian pharmaceutical industry reach new markets, the Indian government has taken up the issue of market access and penetration with China at the highest level. The issue was discussed during Prime Minister Narendra Modi’s recent meeting with President Xi Jinping in Wuhan, China.

On his part, Mr Prabhu said, he had recently taken up the issue of market access and increasing Indian pharma exports to China with the Chinese Commerce Minister Zhong Shan. “The minister agreed for a Round Table meeting so that the issue of market access can be addressed,” he said.

Assuring the global pharmaceutical players and regulators of best quality and affordability of the Indian drugs, Prabhu said pressure on the policy makers to reduce pricing is a global phenomenon, including in the US.

The United States accounted for 31% of India’s $17.27 billion pharma exports in 2017-18. Besides, India has the highest number of US FDA approved plants outside the US.

Prabhu also emphasised the need for reaching out to newer markets in Africa where affordability is the key issue which can be well addressed by the Indian exporters, maintaining top quality.

Commerce Secretary Rita Teotia assured the global pharma community of world class quality, and of keeping prices under check. “Effort is on to ensure uniform quality . We take this seriously and want to ensure that consistent quality and efficacy come out of the Indian products”.

Enumerating the measures to improve Ease of Doing Business, the Drugs Controller General of India, Dr Eswara Reddy, announced increasing the validity of the GMP (Good Manufacturing Practices ) certificate of the World Health Organisation (WHO) guidelines, from two to three years.

Ravi Udaya Bhaskar, director-general of Pharmexcil, said ‘iPhex’ has grown into an international platform for the entire spectrum of the industry and the drug controllers and regulators not only from the key global markets but also from different states.

Source link


The author comredg

Leave a Response